EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases

Sébastien Gendarme iD, Bernard Maitre, Sam Hanash, Jean-Claude Pairon, Florence Canoui-Poitrine, Christos Chouaïd

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Sébastien Gendarme und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Lung Neoplasms, Tomography, X-Ray Computed, Early Detection of Cancer. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation ARC pour la recherche sur le cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer screening programs concern smokers at risk for cardiovascular diseases (CVDs) and chronic obstructive pulmonary disease (COPD). The LUMASCAN (LUng Cancer Screening, MArkers and low-dose computed tomography SCANner) study aimed to evaluate the acceptability and feasibility of screening for these 3 diseases in a community population with centralized organization and to determine low-dose computed tomography (CT) markers associated with each disease.

Methods

This cohort enrolled participants meeting National Comprehensive Cancer Network criteria (v1.2014) in an organized lung cancer–screening program including low-dose CT scans; spirometry; evaluations of coronary artery calcifications (CACs); and a smoking cessation plan at inclusion, 1, and 2 years; then telephone follow-up. Outcomes were the participation rate and the proportion of participants affected by lung cancer, obstructive lung disease, or CVD events. Logistic-regression models were used to identify radiological factors associated with each disease.

Results

Between 2016 and 2019, a total of 302 participants were enrolled: 61% men; median age 58.8 years; 77% active smoker; 11% diabetes; 38% hypertension; and 27% taking lipid-lowering agents. Inclusion, 1-year, and 2-year participation rates were 99%, 81%, 79%, respectively. After a median follow-up of 5.81 years, screenings detected 12 (4%) lung cancer, 9 of 12 via low-dose CT (78% localized) and 3 of 12 during follow-up (all stage IV), 83 (27%) unknown obstructive lung disease, and 131 (43.4%) moderate to severe CACs warranting a cardiology consultation. Preexisting COPD and moderate to severe CACs were associated with major CVD events with odds ratios of 1.98 (95% confident interval [CI] = 1.00 to 3.88) and 3.27 (95% CI = 1.72 to 6.43), respectively.

Conclusion

The LUMASCAN study demonstrated the feasibility of combined screening for lung cancer, COPD, and CVD in a community population. Its centralized organization enabled high participation and coordination of healthcare practitioners.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveLung NeoplasmsTomography, X-Ray ComputedEarly Detection of CancerCardiovascular DiseasesHumansMaleMiddle AgedFemaleAgedSmoking CessationFeasibility StudiesSpirometrySmokingMass ScreeningLogistic Models

Autor:innen und Institutionen

  • Pulmonology Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
  • Inserm U955, IMRB, Université Paris-Est Créteil, Créteil, France.
  • Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Occupational Medicine Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
  • Public Health Department, Henri-Mondor Hospital, Créteil, France.

ORCID-Profile: Sébastien Gendarme

Förderung

  • Fondation ARC pour la recherche sur le cancer

Zitieren

APA

Gendarme, S., Maitre, B., Hanash, S., Pairon, J. C., Canoui-Poitrine, F., & Chouaïd, C. (2024). Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae082

Vancouver

Gendarme S, Maitre B, Hanash S, Pairon JC, Canoui-Poitrine F, Chouaïd C. Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae082

BibTeX
@article{Gendarme2024,
  author = {Gendarme, Sébastien and Maitre, Bernard and Hanash, Sam and Pairon, Jean-Claude and Canoui-Poitrine, Florence and Chouaïd, Christos},
  title = {Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae082}
}
Kostenlos starten →